Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00307086
Status:
COMPLETED
Last Update Posted:
2017-03-06
First Post:
2006-03-23
Brief Title:
Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Organization Data
Organization:
H Lee Moffitt Cancer Center and Research Institute
Class:
OTHER
Study ID:
MCC-14184
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Millennium Pharmaceuticals Inc | INDUSTRY |